Back to Results
First PageMeta Content
Hepatitis C virus / Microbiology / Hepatitis C / Viral load / Medicine / E1 / Boceprevir / Antiviral drug / Hepacivac / HIV/AIDS / Hepatitis / Biology


2012 National Hepatitis C Testing Policy NATIONAL HEPATITIS C TESTING POLICY 1
Add to Reading List

Document Date: 2014-05-21 19:18:22


Open Document

File Size: 217,87 KB

Share Result on Facebook

Company

Sentinel / HCV Ag / /

Country

Australia / /

Event

M&A / FDA Phase / /

Holiday

Commonwealth Day / Commonwealth Day of Australia / /

IndustryTerm

treatment of HCV / diagnostic technologies / treatment services / web links / health services / HCV treatment / web-based provision / consistent management / health care services / blood services / liver services / /

MedicalCondition

insulin resistance / another infection / HIV / disease / HBV / Hepatocellular carcinoma / chronic liver disease / acute hepatitis / Cirrhosis / hepatitis C / hepatitis B / HCV / context Hepatitis C / injury / obesity / liver cancer / liver cirrhosis / infection / chronic infection / illness / liver disease / hepatitis infections / infections / past infection / seroconversion illness / /

MedicalTreatment

antiviral therapy / /

Organization

National Health and Medical Research Council / Blood Borne Virus and STI Subcommittee / National HCV Testing Policy Expert Reference Committee / Blood Borne Virus and Sexually Transmissible Infections Subcommittee of the Australian Population Health Development / Australasian Society for HIV Medicine / Commonwealth Copyright Administration / Australian Population Health Development Principal Committee / Ministerial Advisory Committee on Blood Borne Viruses and Sexually Transmissible Infections / Attorney General’s Department / /

Position

Governor / /

Product

ribavirin / HCV / /

Technology

diagnostic tests / antibodies / genotype / /

URL

http /

SocialTag